Konstantinos Chatzipapas is a Medical Physicist, with research interests at the intersection of medical physics, state-of-the-art computational techniques, and advanced bioprinting technologies. He is passionate about developing innovative solutions to improve radiation bio-dosimetry and optimized clinical applications. More specifically, he has been working on the consequences of radiation to living matter using advanced in-silico methods, focusing on the quantification of cellular damage through Monte Carlo (MC) simulations and Artificial Intelligence (AI). He is keen to collaborate with researchers at all levels, including PhD candidates, Post-Doc researchers, and senior scientists.

Konstantinos is member of GATE, Geant4 and the Geant4-DNA collaboration, and is the contact person for AI developments within Geant4-DNA. He is actively developing the molecularDNA.

His current research encompasses several key areas: developing novel methodologies using MC simulations and AI to quantify cellular response after irradiation, advancing personalized dosimetry methods with specialized pharmacokinetic models (PBPK), exploring 3D bioprinting for creating physical phantoms for medical physics applications, developing online applications leveraging AI to support clinical staff in ionizing radiation techniques, and investigating the potential of digital twins to revolutionize clinical procedures.

Prior to his appointment at Delft University of Technology, he was a Postdoc Researcher at LaTIM, INSERM, Univ. Brest and the LP2i Bordeaux, CNRS, Univ. Bordeaux. He worked also in the private sector with BIOEMTECH to develop novel techniques for paediatric dosimetry, and small animal imaging. He obtained his PhD and MSc in Medical Physics – Radiation Physics at the University of Patras, Greece, studying cellular damage induced by ionizing radiation and paediatric applications of Brachytherapy, accordingly.